Furthermore, in human oral precancerous lesions and cancer cells, curcumin can inhibit the activation of NF-κB and COX-2 induced by the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) [88]. Here, MTCO2P12 is linked to cancer.